LKT Labs

Biochemicals for Life Science Research

Norfloxacin Nicotinate

Norfloxacin Nicotinate

Product ID N5769
Cas No. 118803-81-9
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $37.40 In stock
10 g $104.90 In stock
50 g $337.30 In stock
Bulk Quote

Quicklinks

Description

Norfloxacin is a first generation fluoroquinolone antibiotic that exhibits antibacterial, anti-inflammatory, and anticancer activities. Norfloxacin inhibits DNA gyrase and topoisomerase IV; it is clinically used to treat urinary tract infections and prostatitis. In neutrophils from cirrhotic subjects, norfloxacin increases expression of IL-10 and heme oxygenase 1 (HO-1) and decreases expression of pro-inflammatory cytokines. Additionally, when complexed with gold(III), norfloxacin binds DNA and inhibits cellular proliferation in several cancer cell lines.

Product Info

Cas No.

118803-81-9
Purity

≥98%
Formula

C16H18FN3O3 • C6H5NO2
Formula Wt.

442.44
IUPAC Name

1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;pyridine-3-carboxylic acid
Melting Point

220-227°C
Solubility

Soluble in water.

Appearance

White/Slight Yellow Crystal Powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

N5769 MSDS PDF
Info Sheet

N5769 Info Sheet PDF

References

Gouvea LR, Garcia LS, Lachter DR, et al. Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: relevance of DNA and protein interactions for their mechanism of action. Eur J Med Chem. 2012 Sep;55:67-73. PMID: 22835721.

Gómez-Hurtado I, Zapater P, Bellot P, et al. Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis. Hepatology. 2011 Mar;53(3):935-44. PMID: 21374664.

Padeĭskaia EN. Norfloxacin: more than 20 years of clinical use, the results and place among fluoroquinolones in modern chemotherapy for infections. Antibiot Khimioter. 2003;48(9):28-36. PMID: 15002177.

Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. PMID: 9293187.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A4847

    Amylin, human

    Endogenous peptide hormone inolved in gastric empt...
    ≥95%
  • H1662

    HER2/neu (654-662) GP2

    Peptide fragment of HER2/neu/erbB2 receptor.
    ≥95%
  • H0142

    Haloperidol

    Butyrophenone; σ2 agonist, α1-adrenergic, D2, 5-...
    ≥95%
  • F6803

    FRAX486

    PAK inhibitor.Smo inhibitor.
    ≥98%
  • S1060

    Small Cardioactive Peptide A

    Peptide found in molluscs, cardiomodulator.
    ≥95%
  • C0250

    Calcitonin Gene Related Peptide II, human

    Calcitonin-family peptide, involved in vasodilatio...
    ≥95%
  • C1176

    CCT-128930

    Pyrrolopyrimidine; Akt inhibitor.
    ≥98%
  • C3352

    Cinacalcet Hydrochloride

    Ca2+-sensing receptor agonist.
    ≥99%
  • V3277

    Vitamin E

    Synthetic vitamin E, antioxidant.
    ≥98%
  • F5766

    Forchlorfenuron

    Synthetic cytokinin, plant growth regulator; filam...
    ≥98%
  • P1845

    Pelitinib

    EGFR inhibitor.
    ≥98%
  • C0271

    Carfilzomib

    Epoxomicin analog; proteasome inhibitor.
    ≥98%
  • A4444

    L-Alliin

    Cysteine derivative found in Allium; NMDA NR2A/2B ...
    ≥98%
  • C0248

    Calcineurin Substrate

    Peptide used to measure in vitro calcineurin activ...
    ≥96%
  • T2833

    1-Thio-β-D-glucose Tetraacetate

    Imaging agent; Maillard reaction inhibitor.
    ≥98%
  • V5734

    Vorinostat

    HDAC inhibitor, RNA splicing inhibitor.
    ≥98%
  • R2599

    RGYSLG

    Peptide, represents generic protein kinase active ...
    ≥95%
  • F4679

    Flubendazole

    Benzimidazole; microtubule polymerization inhibito...
    ≥98%
  • F5968

    Foretinib

    ROS1, MET, Ron, Axl, TIE-2, VEGFR2 inhibitor.
    ≥98%
  • E5210

    Endomorphin-1

    Endogenous opioid peptide; μOr agonist.
    ≥95%